1. British Medical Association & Royal Pharmaceutical Society of Great Britain: British National Formulary 39. London: Pharmaceutical Press; 2000
2. Essali MA, Rezk E, Wahlbeck K, et al.: Clozapine v “typical” neuroleptic medication for schizophrenia. In The Cochrane Database of Systematic Reviews, issue 2. Oxford: The Cochrane Collaboration; 1997.
3. Kennedy E, Song F, Hunter R, et al.: Risperidone versus “conventional” antipsychotic medication for schizophrenia. In The Cochrane Database of Systematic Reviews, issue 2. Oxford: The Cochrane Collaboration; 1997.
4. Leucht S, Pitschel-Walz G, Abraham D & Kissling W: Efficacy and extrapyramidal side-effects of new antipsychotics olanzapine, quetiapine, risperidone and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomised controlled trials. Schizophr Res 1999, 35:51–68. Probably the most comprehensive and up-to-date review available.
5. Carpenter WT, Heinrichs DW, Alphs LD: Treatment of negative symptoms. Schizophr Bull 1985, 11:440–452.